Walleye Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.26M Buy
23,800
+11,000
+86% +$3.04M 0.02% 795
2026
Q1
$3.78M Sell
12,800
-3,200
-20% -$951K 0.02% 986
2025
Q4
$4.37M Buy
16,000
+4,300
+37% +$1.17M 0.01% 1245
2025
Q3
$3.16M Sell
11,700
-2,400
-17% -$653K 0.01% 1234
2025
Q2
$3.89M Sell
14,100
-3,800
-21% -$1.03M 0.02% 1038
2025
Q1
$4.75M Buy
17,900
+7,900
+79% +$1.95M 0.02% 819
2024
Q4
$2.32M Sell
10,000
-46,400
-82% -$10.7M 0.01% 1649
2024
Q3
$12.4M Buy
56,400
+37,700
+202% +$7.8M 0.03% 576
2024
Q2
$3.68M Sell
18,700
-10,300
-36% -$2.13M 0.01% 1531
2024
Q1
$6.24M Buy
29,000
+13,300
+85% +$2.79M 0.01% 1144
2023
Q4
$3.31M Sell
15,700
-6,900
-31% -$1.47M 0.01% 1395
2023
Q3
$4.52M Sell
22,600
-18,200
-45% -$3.62M 0.01% 1099
2023
Q2
$7.56M Buy
40,800
+38,100
+1,411% +$7.04M 0.03% 522
2023
Q1
$517K Buy
+2,700
New +$488K 0.01% 1693
2019
Q4
Sell
-5,000
Closed -$1.06M 1850
2019
Q3
$1.06M Sell
5,000
-6,100
-55% -$1.27M 0.06% 425
2019
Q2
$2.15M Buy
+11,100
New +$2.05M 0.24% 80

Other funds holding CME

Walleye Capital's CME Position: Q2 2026 in Review

Walleye Capital reduced its CME Group (CME) stake by 99% in Q2 2026, selling an estimated $17.8M and leaving 832 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #3566.

Walleye Capital first reported a position in CME in Q3 2018 and has held it in 19 quarters since. The position peaked at $19.2M in Q1 2026. 1,705 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Walleye Capital held 832 shares of CME Group worth $184K as of Q2 2026.
  • Walleye Capital sold 64,323 CME Group shares in Q2 2026, an estimated $17.8M.
  • CME Group made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3566 holding.
  • Walleye Capital first reported a position in CME Group in Q3 2018 and has held it in 19 quarters since.
  • Walleye Capital's CME Group position peaked at $19.2M in Q1 2026.
  • 1,705 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.